Scopus h-index:17
- Home
- Profiles
Accepting New Patients
Mount Sinai Doctors
Accepting New PatientsJenny J Lin, MD
Internal Medicine, Primary Care
IMA - Internal Medicine Associates
212-659-8551
- About Me
- Video
- Education & Certifications
- Awards
- Research
- Locations
- Insurance
- Publications
- Patient Experience Rating
- Industry Relationships
About Me
Dr. Lin graduated from Harvard Medical School and completed her residency in Internal Medicine (primary care track) at Beth Israel Deaconess Medical Center in Boston, MA. She is a board-certified internist who practices general internal medicine. Her clinical interests include preventive medicine, diabetes and hypertension management, women's health and cancer survivorship. Her research interests are in cancer survivorship and comorbid disease management and medication adherence. She is the recipient of a National Cancer Institute Career Development Grant to evaluate the impact of a new diagnosis of early-stage cancer on diabetes control and self-management behaviors. She is the fellowship director for the general medicine research fellowship and also continues to actively participate in the medical education of students and residents at Mount Sinai.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Research Topics
Behavior, Cancer, Diabetes
About Me
Dr. Lin graduated from Harvard Medical School and completed her residency in Internal Medicine (primary care track) at Beth Israel Deaconess Medical Center in Boston, MA. She is a board-certified internist who practices general internal medicine. Her clinical interests include preventive medicine, diabetes and hypertension management, women's health and cancer survivorship. Her research interests are in cancer survivorship and comorbid disease management and medication adherence. She is the recipient of a National Cancer Institute Career Development Grant to evaluate the impact of a new diagnosis of early-stage cancer on diabetes control and self-management behaviors. She is the fellowship director for the general medicine research fellowship and also continues to actively participate in the medical education of students and residents at Mount Sinai.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Research Topics
Behavior, Cancer, Diabetes
About Me
Dr. Lin graduated from Harvard Medical School and completed her residency in Internal Medicine (primary care track) at Beth Israel Deaconess Medical Center in Boston, MA. She is a board-certified internist who practices general internal medicine. Her clinical interests include preventive medicine, diabetes and hypertension management, women's health and cancer survivorship. Her research interests are in cancer survivorship and comorbid disease management and medication adherence. She is the recipient of a National Cancer Institute Career Development Grant to evaluate the impact of a new diagnosis of early-stage cancer on diabetes control and self-management behaviors. She is the fellowship director for the general medicine research fellowship and also continues to actively participate in the medical education of students and residents at Mount Sinai.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Research Topics
Behavior, Cancer, Diabetes
Video
Education
BA, Harvard College
MD, Harvard Medical School
MPH, Mailman School of Public Health, Columbia University
Internship, Internal Medicine
Beth Israel Deaconess Medical Center- Harvard Medical School
Residency, Internal Medicine
Beth Israel Deaconess Medical Center- Harvard Medical School
Certifications
American Board of Internal Medicine
Awards
2001
Katherine Swan Ginsburg Award for Humanism in Medicine
1993
Phi Beta Kappa
Harvard University
Research
Cancer survivorship, comorbid disease management, medication adherence, medical education (cross-cultural communication), patient safety and quality assessment.
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- IMA - Internal Medicine AssociatesCenter for Advanced Medicine, 17 East 102nd Street, 7th Floor, New York, NY, 10029
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- AgeWell New York
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Healthplus FKA Amerigroup Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Hotel Trades
- Magnacare-Health Care
- Medicare
- Metroplus
- Multiplan PHCS
- NY Medicaid
- Oxford - Freedom & Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Community Care Medicaid
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Article:59
Review Article:3
Comment/Debate:2
Chapter:2
Recent Artifacts
- Geographic Variation in Colorectal Cancer Incidence Among Asian Americans: A Population-Based Analysis 2006–2016
- The TCI Clinical Encounter Program for PhD Students in Cancer Biology: a Feasibility Pilot
- Cancer beliefs and diet self-management among cancer survivors with comorbid diabetes
- The impact of bone mineral density screening on incident fractures and healthcare resource utilization among postmenopausal breast cancer survivors treated with aromatase inhibitors
- Tisch Cancer Institute Scholars Program: Mentored Cancer Research Training Pipeline for Medical Students
- Association of Vaccination with the Persistence of Post-COVID Symptoms
- Characterizing Beliefs About Breast Cancer and Comorbid Diabetes After Cancer Treatment
- Factor Xa inhibitors versus low molecular weight heparin for the treatment of cancer associated venous thromboembolism; A meta-analysis of randomized controlled trials and non-randomized studies
- An Urgent Need for Guidelines for Telemedicine Use
- Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors
Patient Experience Rating
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
5 out of 5
Care Provider’s Concern
5 out of 5
Likelihood to Recommend Care Provider
5 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Lin did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.